ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Abdul-Rahman Mamdouh Mohammad1, Rehab Mahmoud Abd El-Baky2,3
and Eman Farouk Ahmed3
1Faculty of Pharmacy, Deraya University, Minia 11566, Egypt.
2Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
3Department of Microbiology and Immunology, Faculty of Pharmacy, Deraya University, Minia 11566, Egypt.
J Pure Appl Microbiol. 2020;14(4):2265-2276 | Article Number: 6673 | © The Author(s). 2020
Received: 23/09/2020 | Accepted: 21/10/2020 | Published: 28/12/2020

Mycoplasma pneumoniae is a one of most common reasons of respiratory tract infections in both adolescents and children with severity ranged from moderate to high. Many facts in the previous years regarding infections were induced via this organism having extra pathogenic mechanisms. Clinically, resistance to macrolide has produced internationally and represents a treatment trouble. Antimicrobial sensitivity checking out techniques have been applied, and novel antibiotics which are effective towards M. pneumoniae are present processing development. That evaluate concentrates on the several trends occurring in the previous quite a few years which beautify the grasp of that microorganism, which is one of the smallest pathogenic bacteria; however, is of extreme medical significance.


Mycoplasma pneumoniae, community acquired pneumonia, macrolide resistance, treatment

Article Metrics

Article View: 368

Share This Article

© The Author(s) 2020. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.